SCYX

SCYX

SCYNEXIS Inc. Common Stock

$0.822+-0.000 (-0.000%)

即時價格

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$0.822

最高

$0.822

最低

$0.822

交易量

0.05M

公司基本面

交易統計

相關新聞

GlobeNewswire

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study

First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical holdResumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six

查看更多
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
GlobeNewswire

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update

Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme.Hansoh recently

查看更多
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update